AGE |
Advanced glycation end products |
AMC |
Age-matched controls |
BMI |
Body mass index |
BMD |
Bone mineral density |
CD |
Cluster of differentiation |
CFU-F |
Colony-forming unit fibroblast |
CFU-O |
Colony-forming unit osteoblast |
CO2
|
Carbon dioxide |
DMEM |
Dulbecco’s modified eagle medium |
DM |
Diabetes mellitus |
DMSO |
Dimethyl sulfoxide |
EDTA |
Ethylenediaminetetraacetic acid |
EGM |
Endothelial growth medium |
FBS |
Fetal bovine serum |
FGF |
Fibroblast growth factor |
GDPR |
General data protection regulation (EU) |
HGF |
Hepatocyte growth factor |
HLA-DR |
Human leukocyte antigen—DR isotype |
HUVEC |
Human umbilical vein endothelial cell |
ISCT |
International Society of Cell and Gene Therapy |
MEM |
Minimum essential medium |
MIX |
3-Isobutyl-1-Methyl-Xanthine |
MNC |
Mononuclear cell |
MSC |
Mesenchymal stromal cell |
MTT |
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide |
NBT/BCIP |
p-nitroblue tetrazolium chloride/5-bromo-4-chloro-3-indolyl phosphate |
P |
Passage |
PBS |
Phosphate buffered saline |
PE |
Phycoerythrin |
PS |
Penicillin-Streptomycin |
RAGE |
Receptor for advanced glycation end products |
SEM |
Standard error of the mean |
T2DM |
Type 2 diabetes mellitus |